COMPATIBILITY AND STABILITY OF GRANISETRON, DEXAMETHASONE, AND METHYLPREDNISOLONE IN INJECTABLE SOLUTIONS

被引：11

作者：

PINGUET, F

ROUANET, P

MARTEL, P

FABBRO, M

SALABERT, D

ASTRE, C

机构：

[1] Laboratory of Oncopharmacology, Centre Val D'aurelle Paul Lamarque, Montpellier

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 1995年 / 84卷 / 02期

关键词：

D O I：

10.1002/jps.2600840229

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：267 / 268

页数：2

共 16 条

[1] PHASE-I/II TRIAL OF GRANISETRON - A NOVEL 5-HYDROXYTRYPTAMINE ANTAGONIST FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING [J].

ADDELMAN, M ;

ERLICHMAN, C ;

FINE, S ;

WARR, D ;

MURRAY, C .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (02) :337-341

[2]

ARECHEVALA E, 1992, P AM SOC CLIN ONCOL, V11, P393

[3]

BALTZER L, 1992, P AM SOC CLIN ONCOL, V11, P400

[4]

CUPISSOL DR, 1990, EUR J CANCER, V26, pS23

[5]

DEWET M, 1993, CANCER, V71, P4043, DOI 10.1002/1097-0142(19930615)71:12<4043::AID-CNCR2820711239>3.0.CO

[6]

2-A

[7]

KRIS MG, 1993, CANCER, V72, P3436, DOI 10.1002/1097-0142(19931201)72:11+<3436::AID-CNCR2820721610>3.0.CO

[8]

2-Z

[9]

LOCATELLI MC, 1992, P AM SOC CLIN ONCOL, V11, P391

[10] PROTECTION FROM NAUSEA AND VOMITING IN CISPLATIN-TREATED PATIENTS - HIGH-DOSE METOCLOPRAMIDE COMBINED WITH METHYLPREDNISOLONE VERSUS METOCLOPRAMIDE COMBINED WITH DEXAMETHASONE AND DIPHENHYDRAMINE - A STUDY OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCHR [J].

ROILA, F ;

TONATO, M ;

BASURTO, C ;

PICCIAFUOCO, M ;

BRACARDA, S ;

DONATI, D ;

MALACARNE, P ;

MONICI, L ;

DICOSTANZO, F ;

PATOIA, L ;

BALLATORI, E ;

TOGNONI, G ;

DELFAVERO, A .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) :1693-1700

← 1 2 →